Trulieve Cannabis Corp. 10-Q Summary: Q3 2024
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2024. Trulieve Cannabis Corp. is a vertically integrated multi-state cannabis operator with retail, cultivation, and processing facilities across nine U.S. states. As of the reporting date, the company operated 215 dispensaries and 16 cultivation/processing facilities. The company is currently engaged in a significant legal and regulatory campaign regarding the "Smart & Safe Florida" initiative and the federal rescheduling of cannabis.
Key Financial Metrics
| Metric (in thousands) | Q3 2024 | Q3 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Revenue | $284,284 | $275,210 | $885,345 | $842,219 |
| Gross Profit | $173,278 | $142,946 | $528,728 | $434,775 |
| Gross Margin | 61.0% | 51.9% | 59.7% | 51.6% |
| Net Loss (GAAP) | $(61,856) | $(25,843) | $(99,015) | $(498,346) |
| Adjusted EBITDA | $96,086 | $77,738 | $308,838 | $234,505 |
| Cash & Equivalents | $237,666 | $201,372 | $237,666 | $201,372 |
| Short-term Investments | $80,179 | $0 | $80,179 | $0 |
| Total Debt (Long-term) | $621,372 | $615,729 | $621,372 | $615,729 |
Note: Total Debt includes Private Placement Notes, Notes Payable, and Construction Finance Liabilities. Figures are in thousands.
Material Changes vs. Prior Period
- Revenue Growth: Q3 revenue increased 3.3% year-over-year, driven by the opening of 27 new dispensaries (totaling 215) and increased wholesale sales in Maryland and Pennsylvania.
- Margin Expansion: Gross margin improved significantly to 61.0% (from 51.9% in Q3 2023) due to at-scale cost efficiencies in production facilities.
- Expense Spike: General and Administrative (G&A) expenses surged 137.7% to $81.9 million, primarily due to $48.4 million in legislative campaign contributions related to the Florida ballot initiative, compared to $0.5 million in the prior year.
- Tax Provision: The provision for income taxes increased to $47.4 million (Q3 2024) from $36.6 million (Q3 2023), driven by higher gross profit and interest on uncertain tax positions.
- Cash Flow: Operating cash flow improved dramatically to $240.8 million YTD 2024 (from $70.4 million YTD 2023), largely due to a reduction in net tax payments and improved gross profit.
Guidance, Outlook, and Risks
- Regulatory Catalysts: The company is heavily focused on the November 5, 2024, Florida election for the "Smart & Safe Florida" initiative (adult-use legalization) and the ongoing federal rescheduling of cannabis to Schedule III.
- Operational Expansion: Trulieve continues to expand its footprint, recently acquiring Harvest of Ohio and converting licenses to allow adult-use sales in Columbus, Westerville, and Beavercreek.
- Internal Controls: The company disclosed material weaknesses in internal controls over financial reporting related to information technology and inventory valuation. Remediation efforts are ongoing but not yet concluded.
- Tax Contingencies: Uncertain tax position liabilities increased to $384.1 million, primarily related to the company's legal challenge of IRC Section 280E (which disallows deductions for cannabis businesses).
- Liquidity: Management believes existing cash ($237.7M) and short-term investments ($80.2M) are sufficient to meet requirements for the next 12 months.
Investor Verification Checklist
- Legislative Contributions: Verify the impact of the $48.4M Q3 campaign contribution on future profitability and the likelihood of the Florida ballot initiative passing.
- Tax Liability Exposure: Assess the risk associated with the $384.1M uncertain tax position liability and the company's reliance on the Section 280E legal challenge.
- Internal Control Remediation: Monitor progress on remediation of material weaknesses in IT and inventory valuation to ensure future financial reporting reliability.
- Debt Maturities: Review the $368M private placement notes maturing in October 2026 and the company's refinancing or repayment strategy.
- Inventory Valuation: Given the material weakness in inventory controls, scrutinize the $220.9M inventory balance for potential write-downs.